Department of Cardiology, Yantai Yuhuangding Hospital, Yantai, Shandong, China.
Immun Inflamm Dis. 2024 Aug;12(8):e1369. doi: 10.1002/iid3.1369.
The incidence of coronary heart disease (CHD) in youth is rapidly increasing but difficultly recognized in the early stage.
In this retrospective study, 194 CHD patients under the age of 45 who previously experienced chest pain symptoms and 170 non-CHD patients were included and demographic data were collected. Systemic inflammation index (SII) and systemic inflammation response index (SIRI) were increased in young CHD patients (p < 001). Spearman's correlation analysis showed that both SII and SIRI were negatively correlated with HDL and positively correlated with hypertension, Gensini score, and hsTnI. Logistic regression analysis indicated that SII and SIRI were independently associated with the presence of CHD in youth with chest pain symptoms. The area under the ROC curve (AUC) of the SII model for young CHD patients was 0.805 (0.728-0.869), and the sensitivity and specificity were 0.65 and 0.823, respectively. Meanwhile, the AUC for the SIRI model was 0.812 (0.739-0.872), and the sensitivity and specificity were 0.673 and 0.8022. The calibration curves of both SII and SIRI models are in good agreement with the actual curves. And the decision curves of both models indicated their clinical practicality.
SII and SIRI are independent risk factors for CHD in young adults, which can quickly and effectively identify CHD patients among young adults who have previously experienced chest pain symptoms.
冠心病(CHD)在年轻人中的发病率正在迅速上升,但在早期阶段难以识别。
在这项回顾性研究中,纳入了 194 名年龄在 45 岁以下的曾有胸痛症状的 CHD 患者和 170 名非 CHD 患者,并收集了人口统计学数据。年轻 CHD 患者的全身炎症指数(SII)和全身炎症反应指数(SIRI)升高(p<0.001)。Spearman 相关分析显示,SII 和 SIRI 与 HDL 呈负相关,与高血压、Gensini 评分和 hsTnI 呈正相关。Logistic 回归分析表明,SII 和 SIRI 与有胸痛症状的年轻 CHD 患者 CHD 的存在独立相关。SII 模型对年轻 CHD 患者的 AUC 为 0.805(0.728-0.869),敏感性和特异性分别为 0.65 和 0.823。同时,SIRI 模型的 AUC 为 0.812(0.739-0.872),敏感性和特异性分别为 0.673 和 0.8022。两个模型的校准曲线与实际曲线吻合良好,决策曲线均表明了其临床实用性。
SII 和 SIRI 是年轻人 CHD 的独立危险因素,可快速有效地识别曾有胸痛症状的年轻成年人中的 CHD 患者。